 | • レポートコード：GIR-22F2234 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（2~3営業日） • 産業分類：化学＆材料 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Bio-based Pentylenediamine Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界のバイオベースペンチレンジアミンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 バイオベースペンチレンジアミン市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・ポリアミド、PDI、エポキシ硬化剤、有機合成中間体、その他 アプリケーション別セグメントは次のように区分されます。 ・紡績、エンジニアリング材料、医薬、農薬、有機合成、その他 世界のバイオベースペンチレンジアミン市場の主要な市場プレーヤーは以下のとおりです。 ・Cathay Biotech Inc.、Aphena Pharma Solutions、Bio-Tech Pharmacal、Goodwin Biotechnology、Xenon Pharmaceuticals、Nektar Therapeutics、Midas Pharmaceuticals、Kedrion Biopharma、Xcelthera、Anichem、ALC Bio Innovations、ACADIA Pharmaceuticals、AbbVie Inc.、Ology Bioservices、QMI - Quality Management、Biomiga、Molecular Targeting Technologies 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、バイオベースペンチレンジアミン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なバイオベースペンチレンジアミンメーカーの企業概要、2019年～2022年までのバイオベースペンチレンジアミンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なバイオベースペンチレンジアミンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別バイオベースペンチレンジアミンの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのバイオベースペンチレンジアミンのタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのバイオベースペンチレンジアミン市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびバイオベースペンチレンジアミンの産業チェーンを掲載しています。 ・第13、14、15章では、バイオベースペンチレンジアミンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - バイオベースペンチレンジアミンの概要 - タイプ別分析（2017年vs2021年vs2028年）：ポリアミド、PDI、エポキシ硬化剤、有機合成中間体、その他 - アプリケーション別分析（2017年vs2021年vs2028年）：紡績、エンジニアリング材料、医薬、農薬、有機合成、その他 - 世界のバイオベースペンチレンジアミン市場規模・予測 - 世界のバイオベースペンチレンジアミン生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Cathay Biotech Inc.、Aphena Pharma Solutions、Bio-Tech Pharmacal、Goodwin Biotechnology、Xenon Pharmaceuticals、Nektar Therapeutics、Midas Pharmaceuticals、Kedrion Biopharma、Xcelthera、Anichem、ALC Bio Innovations、ACADIA Pharmaceuticals、AbbVie Inc.、Ology Bioservices、QMI - Quality Management、Biomiga、Molecular Targeting Technologies ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：ポリアミド、PDI、エポキシ硬化剤、有機合成中間体、その他 ・アプリケーション別分析2017年-2028年：紡績、エンジニアリング材料、医薬、農薬、有機合成、その他 ・バイオベースペンチレンジアミンの北米市場分析 - バイオベースペンチレンジアミンの北米市場：タイプ別市場規模2017年-2028年 - バイオベースペンチレンジアミンの北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・バイオベースペンチレンジアミンのヨーロッパ市場分析 - ：バイオベースペンチレンジアミンのヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：バイオベースペンチレンジアミンのヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・バイオベースペンチレンジアミンのアジア太平洋市場分析 - バイオベースペンチレンジアミンのアジア太平洋市場：タイプ別市場規模2017年-2028年 - バイオベースペンチレンジアミンのアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・バイオベースペンチレンジアミンの南米市場分析 - バイオベースペンチレンジアミンの南米市場：タイプ別市場規模2017年-2028年 - バイオベースペンチレンジアミンの南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・バイオベースペンチレンジアミンの中東・アフリカ市場分析 - バイオベースペンチレンジアミンの中東・アフリカ市場：タイプ別市場規模2017年-2028年 - バイオベースペンチレンジアミンの中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Bio-based Pentylenediamine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Bio-based Pentylenediamine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Spinning accounting for % of the Bio-based Pentylenediamine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Polyamide segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Bio-based Pentylenediamine include Cathay Biotech Inc., Aphena Pharma Solutions, Bio-Tech Pharmacal, Goodwin Biotechnology, and Xenon Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Bio-based Pentylenediamine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Polyamide
PDI
Epoxy Curing Agent
Organic Synthesis Intermediate
Others
Market segment by Application can be divided into
Spinning
Engineering Materials
Medicine
Pesticides
Organic Synthesis
Others
The key market players for global Bio-based Pentylenediamine market are listed below:
Cathay Biotech Inc.
Aphena Pharma Solutions
Bio-Tech Pharmacal
Goodwin Biotechnology
Xenon Pharmaceuticals
Nektar Therapeutics
Midas Pharmaceuticals
Kedrion Biopharma
Xcelthera
Anichem
ALC Bio Innovations
ACADIA Pharmaceuticals
AbbVie Inc.
Ology Bioservices
QMI – Quality Management
Biomiga
Molecular Targeting Technologies
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bio-based Pentylenediamine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Bio-based Pentylenediamine, with price, sales, revenue and global market share of Bio-based Pentylenediamine from 2019 to 2022.
Chapter 3, the Bio-based Pentylenediamine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bio-based Pentylenediamine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Bio-based Pentylenediamine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Bio-based Pentylenediamine.
Chapter 13, 14, and 15, to describe Bio-based Pentylenediamine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Bio-based Pentylenediamine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Bio-based Pentylenediamine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Polyamide
1.2.3 PDI
1.2.4 Epoxy Curing Agent
1.2.5 Organic Synthesis Intermediate
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Bio-based Pentylenediamine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Spinning
1.3.3 Engineering Materials
1.3.4 Medicine
1.3.5 Pesticides
1.3.6 Organic Synthesis
1.3.7 Others
1.4 Global Bio-based Pentylenediamine Market Size & Forecast
1.4.1 Global Bio-based Pentylenediamine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Bio-based Pentylenediamine Sales in Volume (2017-2028)
1.4.3 Global Bio-based Pentylenediamine Price (2017-2028)
1.5 Global Bio-based Pentylenediamine Production Capacity Analysis
1.5.1 Global Bio-based Pentylenediamine Total Production Capacity (2017-2028)
1.5.2 Global Bio-based Pentylenediamine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Bio-based Pentylenediamine Market Drivers
1.6.2 Bio-based Pentylenediamine Market Restraints
1.6.3 Bio-based Pentylenediamine Trends Analysis
2 Manufacturers Profiles
2.1 Cathay Biotech Inc.
2.1.1 Cathay Biotech Inc. Details
2.1.2 Cathay Biotech Inc. Major Business
2.1.3 Cathay Biotech Inc. Bio-based Pentylenediamine Product and Services
2.1.4 Cathay Biotech Inc. Bio-based Pentylenediamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Aphena Pharma Solutions
2.2.1 Aphena Pharma Solutions Details
2.2.2 Aphena Pharma Solutions Major Business
2.2.3 Aphena Pharma Solutions Bio-based Pentylenediamine Product and Services
2.2.4 Aphena Pharma Solutions Bio-based Pentylenediamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Bio-Tech Pharmacal
2.3.1 Bio-Tech Pharmacal Details
2.3.2 Bio-Tech Pharmacal Major Business
2.3.3 Bio-Tech Pharmacal Bio-based Pentylenediamine Product and Services
2.3.4 Bio-Tech Pharmacal Bio-based Pentylenediamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Goodwin Biotechnology
2.4.1 Goodwin Biotechnology Details
2.4.2 Goodwin Biotechnology Major Business
2.4.3 Goodwin Biotechnology Bio-based Pentylenediamine Product and Services
2.4.4 Goodwin Biotechnology Bio-based Pentylenediamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Xenon Pharmaceuticals
2.5.1 Xenon Pharmaceuticals Details
2.5.2 Xenon Pharmaceuticals Major Business
2.5.3 Xenon Pharmaceuticals Bio-based Pentylenediamine Product and Services
2.5.4 Xenon Pharmaceuticals Bio-based Pentylenediamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Nektar Therapeutics
2.6.1 Nektar Therapeutics Details
2.6.2 Nektar Therapeutics Major Business
2.6.3 Nektar Therapeutics Bio-based Pentylenediamine Product and Services
2.6.4 Nektar Therapeutics Bio-based Pentylenediamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Midas Pharmaceuticals
2.7.1 Midas Pharmaceuticals Details
2.7.2 Midas Pharmaceuticals Major Business
2.7.3 Midas Pharmaceuticals Bio-based Pentylenediamine Product and Services
2.7.4 Midas Pharmaceuticals Bio-based Pentylenediamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Kedrion Biopharma
2.8.1 Kedrion Biopharma Details
2.8.2 Kedrion Biopharma Major Business
2.8.3 Kedrion Biopharma Bio-based Pentylenediamine Product and Services
2.8.4 Kedrion Biopharma Bio-based Pentylenediamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Xcelthera
2.9.1 Xcelthera Details
2.9.2 Xcelthera Major Business
2.9.3 Xcelthera Bio-based Pentylenediamine Product and Services
2.9.4 Xcelthera Bio-based Pentylenediamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Anichem
2.10.1 Anichem Details
2.10.2 Anichem Major Business
2.10.3 Anichem Bio-based Pentylenediamine Product and Services
2.10.4 Anichem Bio-based Pentylenediamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 ALC Bio Innovations
2.11.1 ALC Bio Innovations Details
2.11.2 ALC Bio Innovations Major Business
2.11.3 ALC Bio Innovations Bio-based Pentylenediamine Product and Services
2.11.4 ALC Bio Innovations Bio-based Pentylenediamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 ACADIA Pharmaceuticals
2.12.1 ACADIA Pharmaceuticals Details
2.12.2 ACADIA Pharmaceuticals Major Business
2.12.3 ACADIA Pharmaceuticals Bio-based Pentylenediamine Product and Services
2.12.4 ACADIA Pharmaceuticals Bio-based Pentylenediamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 AbbVie Inc.
2.13.1 AbbVie Inc. Details
2.13.2 AbbVie Inc. Major Business
2.13.3 AbbVie Inc. Bio-based Pentylenediamine Product and Services
2.13.4 AbbVie Inc. Bio-based Pentylenediamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Ology Bioservices
2.14.1 Ology Bioservices Details
2.14.2 Ology Bioservices Major Business
2.14.3 Ology Bioservices Bio-based Pentylenediamine Product and Services
2.14.4 Ology Bioservices Bio-based Pentylenediamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 QMI – Quality Management
2.15.1 QMI – Quality Management Details
2.15.2 QMI – Quality Management Major Business
2.15.3 QMI – Quality Management Bio-based Pentylenediamine Product and Services
2.15.4 QMI – Quality Management Bio-based Pentylenediamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Biomiga
2.16.1 Biomiga Details
2.16.2 Biomiga Major Business
2.16.3 Biomiga Bio-based Pentylenediamine Product and Services
2.16.4 Biomiga Bio-based Pentylenediamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Molecular Targeting Technologies
2.17.1 Molecular Targeting Technologies Details
2.17.2 Molecular Targeting Technologies Major Business
2.17.3 Molecular Targeting Technologies Bio-based Pentylenediamine Product and Services
2.17.4 Molecular Targeting Technologies Bio-based Pentylenediamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Bio-based Pentylenediamine Breakdown Data by Manufacturer
3.1 Global Bio-based Pentylenediamine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Bio-based Pentylenediamine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Bio-based Pentylenediamine
3.4 Market Concentration Rate
3.4.1 Top 3 Bio-based Pentylenediamine Manufacturer Market Share in 2021
3.4.2 Top 6 Bio-based Pentylenediamine Manufacturer Market Share in 2021
3.5 Global Bio-based Pentylenediamine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Bio-based Pentylenediamine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Bio-based Pentylenediamine Market Size by Region
4.1.1 Global Bio-based Pentylenediamine Sales in Volume by Region (2017-2028)
4.1.2 Global Bio-based Pentylenediamine Revenue by Region (2017-2028)
4.2 North America Bio-based Pentylenediamine Revenue (2017-2028)
4.3 Europe Bio-based Pentylenediamine Revenue (2017-2028)
4.4 Asia-Pacific Bio-based Pentylenediamine Revenue (2017-2028)
4.5 South America Bio-based Pentylenediamine Revenue (2017-2028)
4.6 Middle East and Africa Bio-based Pentylenediamine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Bio-based Pentylenediamine Sales in Volume by Type (2017-2028)
5.2 Global Bio-based Pentylenediamine Revenue by Type (2017-2028)
5.3 Global Bio-based Pentylenediamine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Bio-based Pentylenediamine Sales in Volume by Application (2017-2028)
6.2 Global Bio-based Pentylenediamine Revenue by Application (2017-2028)
6.3 Global Bio-based Pentylenediamine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Bio-based Pentylenediamine Sales by Type (2017-2028)
7.2 North America Bio-based Pentylenediamine Sales by Application (2017-2028)
7.3 North America Bio-based Pentylenediamine Market Size by Country
7.3.1 North America Bio-based Pentylenediamine Sales in Volume by Country (2017-2028)
7.3.2 North America Bio-based Pentylenediamine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Bio-based Pentylenediamine Sales by Type (2017-2028)
8.2 Europe Bio-based Pentylenediamine Sales by Application (2017-2028)
8.3 Europe Bio-based Pentylenediamine Market Size by Country
8.3.1 Europe Bio-based Pentylenediamine Sales in Volume by Country (2017-2028)
8.3.2 Europe Bio-based Pentylenediamine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Bio-based Pentylenediamine Sales by Type (2017-2028)
9.2 Asia-Pacific Bio-based Pentylenediamine Sales by Application (2017-2028)
9.3 Asia-Pacific Bio-based Pentylenediamine Market Size by Region
9.3.1 Asia-Pacific Bio-based Pentylenediamine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Bio-based Pentylenediamine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Bio-based Pentylenediamine Sales by Type (2017-2028)
10.2 South America Bio-based Pentylenediamine Sales by Application (2017-2028)
10.3 South America Bio-based Pentylenediamine Market Size by Country
10.3.1 South America Bio-based Pentylenediamine Sales in Volume by Country (2017-2028)
10.3.2 South America Bio-based Pentylenediamine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Bio-based Pentylenediamine Sales by Type (2017-2028)
11.2 Middle East & Africa Bio-based Pentylenediamine Sales by Application (2017-2028)
11.3 Middle East & Africa Bio-based Pentylenediamine Market Size by Country
11.3.1 Middle East & Africa Bio-based Pentylenediamine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Bio-based Pentylenediamine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Bio-based Pentylenediamine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Bio-based Pentylenediamine
12.3 Bio-based Pentylenediamine Production Process
12.4 Bio-based Pentylenediamine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Bio-based Pentylenediamine Typical Distributors
13.3 Bio-based Pentylenediamine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer